Clinical Diabetes Therapeutics and Diagnostics

The relative abundance of lack of rigorous exercise and food common in modern life pose serious challenges in the incidence and treatment of these diseases and their complications. Although blood glucose controlling agents such as oral hypoglycaemic agents and insulin are available, most currently available drugs have been shown to exhibit minimal to moderate efficacy and many of them have serious side effects. Obesity is an important risk factor for type 2 diabetes. Weight loss in patients with type 2 diabetes is associated with improved glycaemic control and reduced cardiovascular disease risk factors, but weight loss is notably difficult to achieve and sustain with caloric restriction and exercise.

  • Diet, Physical Activity, and Behavioral Therapy
  • Obesity with antidiuretic drugs
  • Pharmacologic Interventions
  • Assessment of glycemic control

Related Conference of Clinical Diabetes Therapeutics and Diagnostics

February 27-28, 2019

Asia Pacific Diabetes and Endocrinology Congress

Tokyo, Japan

April 17-18, 2019

21st Asia Pacific Diabetes Conference

Osaka,Japan
May 17-18, 2019

2nd Global Experts Meeting on Diabetes, Hypertension & Metabolic Syndrome

Holiday Inn Singapore Atrium | Singapore
May 30-31, 2019

2nd Global Meeting on Diabetes and Endocrinology

Istanbul, Turkey
June 27-28, 2019 |

18th Global Conference on Diabetes & Nursing Care

Amsterdam, Netherlands
July 17-18, 2019

28th European Diabetes Congress

| Edinburgh, Scotland
July 24-25, 2019

29th World Diabetes & Heart Congress

Melbourne, Australia
July 29-30, 2019

12th International Conference on Diabetes & Metabolism

Chicago | Illinois| USA
September 19-20, 2019

15th World Congress on Endocrinology & Diabetes

| Prague, Czech Republic
Oct 03-04, 2019

Euro Diabetes Congress & Expo

| Paris, France

Clinical Diabetes Therapeutics and Diagnostics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in